Revisiting high-density lipoprotein cholesterol in cardiovascular disease: Is too much of a good thing always a good thing?
<p dir="ltr">Cardiovascular disease (CVD) continues to be a leading cause of global mortality and morbidity. Various established risk factors are linked to CVD, and modifying these risk factors is fundamental in CVD management. Clinical studies underscore the association between dysl...
Saved in:
| Main Author: | Mohammad Al Zein (20090700) (author) |
|---|---|
| Other Authors: | Alicia Khazzeka (20090703) (author), Alessandro El Khoury (20090706) (author), Jana Al Zein (20090709) (author), Dima Zoghaib (20090712) (author), Ali H. Eid (5461829) (author) |
| Published: |
2024
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reduced HDL-cholesterol in long COVID-19: A key metabolic risk factor tied to disease severity
by: Jamila, Al-Zadjali
Published: (2024) -
Health benefits of sesamin on cardiovascular disease and its associated risk factors
by: Dalibalta, Sarah
Published: (2020) -
Metal-based nanoparticles: Promising tools for the management of cardiovascular diseases
by: Nour K., Younis
Published: (2021) -
Intermittent Fasting Regulates Metabolic Homeostasis and Improves Cardiovascular Health
by: Rawan Diab (16941484)
Published: (2024) -
Lipid profile in Parkinson's disease: The potential role of brain-derived neurotrophic factor
by: Mahmoud A. Alomari (14780446)
Published: (2022)